Stryker Corporation (SYK)
Summary
Stryker Launches Mako RPS to Expand Robotic Knee Surgery Portfolio
SYK launches Mako RPS, expanding into handheld robotics for total knee replacement and broadening access to robotic-assisted orthopedic procedures.
Stryker: Medtech On Sale, Benefiting From Industry Growth
Stryker Corporation offers a compelling medtech investment, benefiting from robust industry growth and an innovation-led strategy. SYK trades at a 13% discount to fair value, with a forward P/E of 20.1 versus a 10-year average of 25.6. Consensus expects SYK's adjusted diluted EPS to compound at 11.2% annually through 2028, supporting high single-digit dividend growth.
Stryker: The Reshaped Product Portfolio Will Drive Growth
Stryker is a Dividend Aristocrat with 32 years of increases, robust cash flow, and a strong M&A-driven growth strategy. SYK's Q1 2026 results were impacted by a cybersecurity incident, but management maintained full-year guidance and expects normalization. The stock trades at ~21x 2026E EPS, below its 5-year average, suggesting undervaluation despite recent share price declines.
Stryker Corporation Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| TJD Thomas John Drogan PR Inc.IPAL SECURITIES Inc. | 13,640 | $4.47M | $4.32M | -$149,592.14 | -3.35% |
| DI David Izzi Brown, LISLE/CUMMINGS Inc. | 6,876 | $2.03M | $2.18M | $148,658.74 | 7.33% |
| TMB Timothy M. Bidwell Hazlett, BURT & WATSON Inc. | 408 | $111,873.57 | $129,152.36 | $17,278.79 | 15.44% |
| LC Lisa Candera CIGNA INVESTMENTS Inc. /NEW | 3,266 | $677,222.55 | $1.03M | $356,629.42 | 52.66% |
 Stonebridge Capital Management Stonebridge Capital Management Inc. | 25,960 | $1.61M | $8.22M | $6.61M | 410.49% |
Stryker Corporation (SYK) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Stryker Corporation ever had a stock split?
Stryker Corporation Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Kevin A. Lobo CEO | NYSE Exchange | 863667101 CUSIP |
| US Country | 53,000 Employees | 30 Jun 2026 Last Dividend | 17 May 2004 Last Split | - IPO Date |
Overview
Stryker Corporation is a leading medical technology company with a primary focus on providing innovative solutions in the medical field. The company operates through two main segments: MedSurg and Neurotechnology, and Orthopaedics and Spine. These segments cater to a wide array of medical needs, from total joint replacements and trauma surgeries to advanced neurosurgical and neurovascular solutions. Founded in 1941 and based in Portage, Michigan, Stryker has grown into a global entity, distributing its products in approximately 75 countries. The company's commitment to enhancing patient and caregiver outcomes is evident through its extensive product portfolio, advanced medical devices, and a strategic approach to market distribution and customer engagement.
Products and Services
Stryker Corporation offers a diverse range of products and services designed to cater to various facets of medical care, spanning various specialties and requirements. These include:
- Orthopaedics and Spine: This involves providing implants used in total joint replacements for hip, knee, and shoulder surgeries, along with trauma and extremities surgeries. The segment is also known for its spinal implant products, which consist of systems for cervical and thoracolumbar applications, including fixation, minimally invasive, and interbody systems targeted at spinal injury, complex spine, and degenerative therapies.
- MedSurg and Neurotechnology: A broad range of surgical equipment and surgical navigation systems fall under this segment, alongside endoscopic and communications systems. Stryker also offers products aimed at enhancing patient handling, emergency medical care, and intensive care through disposable products, reprocessed and remanufactured medical devices. Additionally, clinical communication and workflow solutions, along with a variety of medical device products for different specialties, are provided, focusing on patient and caregiver safety technologies.
- Neurosurgical, Neurovascular, and Craniomaxillofacial Implant Products: This category includes products for minimally invasive endovascular procedures, brain and open skull-based surgical procedures, and biosurgery products like synthetic bone grafts and vertebral augmentation products. For the treatment of acute ischemic and hemorrhagic stroke, minimally invasive products are offered. The segment also covers craniomaxillofacial implant products, including devices for cranial, maxillofacial, and chest wall surgeries, as well as dural substitutes and sealants.
These products are made available to doctors, hospitals, and other healthcare facilities through a blend of company-owned subsidiaries and branches, supplemented by a network of third-party dealers and distributors worldwide.
